ATyr Common Stock vs Accounts Payable Analysis
| ATYR Stock | 3.44 0.15 4.56% |
ATyr Pharma, financial indicator trend analysis is way more than just evaluating aTyr Pharma, prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether aTyr Pharma, is a good investment. Please check the relationship between ATyr Pharma, Common Stock and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in aTyr Pharma,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in ATyr Stock, please use our How to Invest in ATyr Pharma, guide.
Common Stock vs Accounts Payable
Common Stock vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of aTyr Pharma, Common Stock account and Accounts Payable. At this time, the significance of the direction appears to have very strong relationship.
The correlation between ATyr Pharma,'s Common Stock and Accounts Payable is 0.84. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of aTyr Pharma,, assuming nothing else is changed. The correlation between historical values of ATyr Pharma,'s Common Stock and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of aTyr Pharma, are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Common Stock i.e., ATyr Pharma,'s Common Stock and Accounts Payable go up and down completely randomly.
Correlation Coefficient | 0.84 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Common Stock
Accounts Payable
An accounting item on the balance sheet that represents ATyr Pharma, obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of aTyr Pharma, are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most indicators from ATyr Pharma,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into aTyr Pharma, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in aTyr Pharma,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in ATyr Stock, please use our How to Invest in ATyr Pharma, guide.At this time, ATyr Pharma,'s Sales General And Administrative To Revenue is relatively stable compared to the past year. As of 11/28/2024, Enterprise Value is likely to grow to about 89.6 M, while Selling General Administrative is likely to drop slightly above 12.9 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 32.7M | 55.1M | 55.3M | 46.2M | Cost Of Revenue | 1.3M | 1.7M | 2.7M | 4.6M |
ATyr Pharma, fundamental ratios Correlations
Click cells to compare fundamentals
ATyr Pharma, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with ATyr Pharma,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ATyr Pharma, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma, will appreciate offsetting losses from the drop in the long position's value.Moving together with ATyr Stock
| 0.78 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
Moving against ATyr Stock
| 0.87 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.78 | NKTX | Nkarta Inc Buyout Trend | PairCorr |
| 0.77 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.74 | PEPG | PepGen | PairCorr |
| 0.62 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
The ability to find closely correlated positions to ATyr Pharma, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ATyr Pharma, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ATyr Pharma, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling aTyr Pharma, to buy it.
The correlation of ATyr Pharma, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ATyr Pharma, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if aTyr Pharma, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ATyr Pharma, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for ATyr Stock Analysis
When running ATyr Pharma,'s price analysis, check to measure ATyr Pharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma, is operating at the current time. Most of ATyr Pharma,'s value examination focuses on studying past and present price action to predict the probability of ATyr Pharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma,'s price. Additionally, you may evaluate how the addition of ATyr Pharma, to your portfolios can decrease your overall portfolio volatility.